Literature DB >> 27873305

Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States.

Abe Dunn1, Scott D Grosse2, Samuel H Zuvekas3.   

Abstract

OBJECTIVE: To provide guidance on selecting the most appropriate price index for adjusting health expenditures or costs for inflation. DATA SOURCES: Major price index series produced by federal statistical agencies. STUDY
DESIGN: We compare the key characteristics of each index and develop suggestions on specific indexes to use in many common situations and general guidance in others. DATA COLLECTION/EXTRACTION
METHODS: Price series and methodological documentation were downloaded from federal websites and supplemented with literature scans. PRINCIPAL
FINDINGS: The gross domestic product implicit price deflator or the overall Personal Consumption Expenditures (PCE) index is preferable to the Consumer Price Index (CPI-U) to adjust for general inflation, in most cases. The Personal Health Care (PHC) index or the PCE health-by-function index is generally preferred to adjust total medical expenditures for inflation. The CPI medical care index is preferred for the adjustment of consumer out-of-pocket expenditures for inflation. A new, experimental disease-specific Medical Care Expenditure Index is now available to adjust payments for disease treatment episodes.
CONCLUSIONS: There is no single gold standard for adjusting health expenditures for inflation. Our discussion of best practices can help researchers select the index best suited to their study. © Published 2016. This article is a U.S. Government work and is in the public domain in the USA.

Keywords:  Health care costs; cost-effectiveness; cost-of-illness; expenditures; health care prices; inflation

Mesh:

Year:  2016        PMID: 27873305      PMCID: PMC5785315          DOI: 10.1111/1475-6773.12612

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  19 in total

1.  Health spending growth at a historic low in 2008.

Authors:  Micah Hartman; Anne Martin; Olivia Nuccio; Aaron Catlin
Journal:  Health Aff (Millwood)       Date:  2010 Jan-Feb       Impact factor: 6.301

2.  "An overview of the NHEA with implications for cost analysis researchers".

Authors:  Stephen Heffler; Olivia Nuccio; Mark Freeland
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

3.  Policy makers will need a way to update bundled payments that reflects highly skewed spending growth of various care episodes.

Authors:  Allison B Rosen; Ana Aizcorbe; Alexander J Ryu; Nicole Nestoriak; David M Cutler; Michael E Chernew
Journal:  Health Aff (Millwood)       Date:  2013-05       Impact factor: 6.301

4.  The growth in cost per case explains far more of US health spending increases than rising disease prevalence.

Authors:  Charles S Roehrig; David M Rousseau
Journal:  Health Aff (Millwood)       Date:  2011-09       Impact factor: 6.301

5.  National health spending in 2011: overall growth remains low, but some payers and services show signs of acceleration.

Authors:  Micah Hartman; Anne B Martin; Joseph Benson; Aaron Catlin
Journal:  Health Aff (Millwood)       Date:  2013-01       Impact factor: 6.301

6.  Implications of utilization shifts on medical-care price measurement.

Authors:  Abe Dunn; Eli Liebman; Adam Hale Shapiro
Journal:  Health Econ       Date:  2014-03-04       Impact factor: 3.046

7.  Decomposing growth in spending finds annual cost of treatment contributed most to spending growth, 1980-2006.

Authors:  Martha Starr; Laura Dominiak; Ana Aizcorbe
Journal:  Health Aff (Millwood)       Date:  2014-05       Impact factor: 6.301

8.  Measuring health care costs of individuals with employer-sponsored health insurance in the U.S.: A comparison of survey and claims data.

Authors:  Ana Aizcorbe; Eli Liebman; Sarah Pack; David M Cutler; Michael E Chernew; Allison B Rosen
Journal:  Stat J IAOS       Date:  2012

Review 9.  Challenges in building disease-based national health accounts.

Authors:  Allison B Rosen; David M Cutler
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

10.  Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S.

Authors:  Scott D Grosse; Robert J Berry; J Mick Tilford; James E Kucik; Norman J Waitzman
Journal:  Am J Prev Med       Date:  2016-01-11       Impact factor: 5.043

View more
  137 in total

1.  Buprenorphine Use and Spending for Opioid Use Disorder Treatment: Trends From 2003 to 2015.

Authors:  Andrew W Roberts; Brendan Saloner; Stacie B Dusetzina
Journal:  Psychiatr Serv       Date:  2018-05-08       Impact factor: 3.084

2.  Effects of improvements in the CPS on the estimated prevalence of medical financial burdens.

Authors:  Steven C Hill; Keisha T Solomon; Johanna Catherine Maclean; Michael F Pesko
Journal:  Health Serv Res       Date:  2019-04-29       Impact factor: 3.402

3.  The Impact of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infections on Postdischarge Health Care Costs and Utilization across Multiple Health Care Systems.

Authors:  Richard E Nelson; Makoto Jones; Chuan-Fen Liu; Matthew H Samore; Martin E Evans; Vanessa W Stevens; Thomas Reese; Michael A Rubin
Journal:  Health Serv Res       Date:  2018-10-09       Impact factor: 3.402

4.  Costs Associated with Health Care Services Accessed through VA and in the Community through Medicare for Veterans Experiencing Homelessness.

Authors:  Richard E Nelson; Ying Suo; Warren Pettey; Megan Vanneman; Ann Elizabeth Montgomery; Thomas Byrne; Jamison D Fargo; Adi V Gundlapalli
Journal:  Health Serv Res       Date:  2018-09-23       Impact factor: 3.402

5.  Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005-2007 and 2015-2017.

Authors:  Xilin Zhou; Sundar S Shrestha; Hui Shao; Ping Zhang
Journal:  Diabetes Care       Date:  2020-07-31       Impact factor: 19.112

6.  Association of Utilization Management Policy With Uptake of Hypofractionated Radiotherapy Among Patients With Early-Stage Breast Cancer.

Authors:  Ravi B Parikh; Ezra Fishman; Winnie Chi; Robert P Zimmerman; Atul Gupta; John J Barron; Gosia Sylwestrzak; Justin E Bekelman
Journal:  JAMA Oncol       Date:  2020-06-01       Impact factor: 31.777

7.  Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation.

Authors:  Bart S Ferket; Vinod H Thourani; Pierre Voisine; Samuel F Hohmann; Helena L Chang; Peter K Smith; Robert E Michler; Gorav Ailawadi; Louis P Perrault; Marissa A Miller; Karen O'Sullivan; Stephanie L Mick; Emilia Bagiella; Michael A Acker; Ellen Moquete; Judy W Hung; Jessica R Overbey; Anuradha Lala; Margaret Iraola; James S Gammie; Annetine C Gelijns; Patrick T O'Gara; Alan J Moskowitz
Journal:  J Thorac Cardiovasc Surg       Date:  2019-07-02       Impact factor: 5.209

8.  Trends in procedure type, patient characteristics, and outcomes among persons with knee osteoarthritis undergoing bariatric surgery, 2005-2014.

Authors:  Y Gong; F Selzer; B Deshpande; E Losina
Journal:  Osteoarthritis Cartilage       Date:  2018-07-31       Impact factor: 6.576

9.  Cost of pharmacotherapy for opioid use disorders following inpatient detoxification.

Authors:  Kathryn E McCollister; Jared A Leff; Xuan Yang; Joshua D Lee; Edward V Nunes; Patricia Novo; John Rotrosen; Bruce R Schackman; Sean M Murphy
Journal:  Am J Manag Care       Date:  2018-11       Impact factor: 2.229

10.  Cost-Effectiveness of Routine Screening for Autoimmune Encephalitis in Patients With First-Episode Psychosis in the United States.

Authors:  Eric L Ross; Jessica E Becker; Jenny J Linnoila; Djøra I Soeteman
Journal:  J Clin Psychiatry       Date:  2020-11-17       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.